Latest Breaking News On - Modcs bourayne - Page 1 : vimarsana.com

Senhwa Biosciences, Inc. announced that Taiwan Food and Drug Administration has approved its Phase II IND application of Silmitasertib to treat patients with community-acquired pneumonia caused by.

National taiwan universityT ai peiNational taiwan university hospitalModcs bourayneNational taiwan university cancer centerMinistry of healthDrug administrationSenhwa biosciences incSenhwa biosciencesTaiwan foodFar eastern memorial hospitalTri service general hospitalTaoyuan general hospital